ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 225 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,328 | +106460.0% | 115 | 0.0% | 0.00% | – |
| Q3 2022 | $5 | -28.6% | 115 | 0.0% | 0.00% | – |
| Q2 2022 | $7 | -12.5% | 115 | 0.0% | 0.00% | – |
| Q1 2022 | $8 | -20.0% | 115 | 0.0% | 0.00% | – |
| Q4 2021 | $10 | 0.0% | 115 | 0.0% | 0.00% | – |
| Q3 2021 | $10 | -9.1% | 115 | 0.0% | 0.00% | – |
| Q2 2021 | $11 | -15.4% | 115 | 0.0% | 0.00% | – |
| Q1 2021 | $13 | -13.3% | 115 | +8.5% | 0.00% | – |
| Q4 2020 | $15 | – | 106 | – | 0.00% | – |
Download | ||||||